The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Inflammatory myofibroblastic tumours: where are we now?
Open accessAbstract
Inflammatory pseudotumour is a generic term applied to a variety of neoplastic and non-neoplastic entities that share a common histological appearance, namely a cytologically bland spindle cell proliferation with a prominent, usually chronic inflammatory infiltrate. Over the last two decades, inflammatory myofibroblastic tumour (IMT) has emerged from within the broad category of inflammatory pseudotumour, with distinctive clinical, pathological and molecular features. IMT shows a predilection for the visceral soft tissues of children and adolescents and has a tendency for local recurrence, but only a small risk of distant metastasis. Characteristic histological patterns include the fasciitis-like, compact spindle cell and hypocellular fibrous patterns, which are often seen in combination within the same tumour. Chromosomal translocations leading to activation of the ALK tyrosine kinase can be detected in approximately 50% of IMTs, particularly those arising in young patients. This review will examine the clinical, pathological, and molecular genetic features of IMT and discuss an approach to diagnosis and differential diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K., & Mertens, F. (2002) · Lund University Publications (Lund University) · Cited by 4,467
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K. K., & Mertens, F. (2002) · Medical Entomology and Zoology · Cited by 2,073
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Case 46-1963: Ascites, Jaundice and Hepatomegaly
Stoeckle, J. D., & Scully, R. E. (1963) · New England Journal of Medicine · doi:10.1056/nejm196307112690210 · Cited by 1,502
A new clinicopathological entity of IgG4-related autoimmune disease
Kamisawa, T., Funata, N., Hayashi, Y., Eishi, Y., Koike, M., Tsuruta, K., Okamoto, A., Egawa, N., & Nakajima, H. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1175-y · Cited by 1,457
Coffin, C. M., Hornick, J. L., & Fletcher, C. D. M. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213393.57322.c7 · Cited by 1,006
Self-citationPathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Lawrence, B., Perez-Atayde, A., Hibbard, M. K., Rubin, B. P., Dal Cin, P., Pinkus, J. L., Pinkus, G. S., Xiao, S., Yi, E. S., Fletcher, C. D. M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64550-6 · Cited by 714
Binh, M. B. N., Sastre-Garau, X., Guillou, L., Pinieux, G. D., Terrier, P., Lagacé, R., Aurias, A., Hostein, I., & Coindre, J. M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000170343.09562.39 · Cited by 639
Henricks, W. H., Chu, Y. C., Goldblum, J. R., & Weiss, S. W. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199703000-00002 · Cited by 632
Miettinen, M., Sobin, L. H., & Sarlomo-Rikala, M. (2000) · Modern Pathology · doi:10.1038/modpathol.3880210 · Cited by 626
Pulford, K. A. F., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.4.1394 · Cited by 578
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin, C. A., Hawkins, A. L., Dvorak, C. C., Henkle, C., Ellingham, T. J., & Perlman, E. J. (1999) · PubMed · Cited by 571
Zen, Y., Harada, K., Sasaki, M., Sato, Y., Tsuneyama, K., Haratake, J., Kurumaya, H., Katayanagi, K., Masuda, S., Niwa, H., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000136449.37936.6c · Cited by 539
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease
Kamisawa, T., & Okamoto, A. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1862-6 · Cited by 466
COMINGS, D. E., SKUBI, K. B., VAN EYES, J., & MOTULSKY, A. G. (1967) · Annals of Internal Medicine · doi:10.7326/0003-4819-66-5-884 · Cited by 395
Case Records of the Massachusetts General Hospital (Case 12-1998)
(1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390621 · Cited by 386
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., Lui, M. Y., Colleoni, G. W. B., Antonescu, C. R., Ladanyi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61711-7 · Cited by 359
McCormick, D., Mentzel, T., Beham, A., & Fletcher, C. D. M. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199412000-00004 · Cited by 324
Nuclear beta-catenin in mesenchymal tumors
Ng, T. L., Gown, A. M., Barry, T. S., Cheang, M. C. U., Chan, A. K. W., Turbin, D. A., Hsu, F. D., West, R. B., & Nielsen, T. O. (2005) · Modern Pathology · doi:10.1038/modpathol.3800272 · Cited by 294
Cools, J., Włodarska, I., Somers, R., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10033 · Cited by 292
Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor
Ma, Z., Hill, D. A., Collins, M. H., Morris, S. W., Sumegi, J., Zhou, M., Zuppan, C., & Bridge, J. A. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10177 · Cited by 280
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis
Corradi, D., Maestri, R., Palmisano, A., Bosio, S., Greco, P., Manenti, L., Ferretti, S., Cobelli, R., Moroni, G., Dei Tos, A. P., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002427 · Cited by 197
Debelenko, L. V., Arthur, D. C., Pack, S. D., Helman, L. J., Schrump, D. S., & Tsokos, M. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000088856.49388.ea · Cited by 163
Coindre, J., Hostein, I., Maire, G., Derré, J., Guillou, L., Leroux, A., Ghnassia, J., Collin, F., Pédeutour, F., & Aurias, A. (2004) · The Journal of Pathology · doi:10.1002/path.1579 · Cited by 154
Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor
Panagopoulos, I., Nilsson, T., Domanski, H. A., Isaksson, M., Lindblom, P., Mertens, F., & Mandahl, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21490 · Cited by 126
Biselli, R., Boldrini, R., Ferlini, C., Boglino, C., Inserra, A., & Bosman, C. (1999) · Pathology - Research and Practice · doi:10.1016/s0344-0338(99)80127-7 · Cited by 79
Cytokeratin-Positive Malignant Tumors With Reticulum Cell Morphology
Chan, A. C. L., Serrano‐Olmo, J., Erlandson, R. A., & Rosaí, J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00013 · Cited by 65
Tamas, E. F., & Epstein, J. I. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213367.41251.5d · Cited by 35
(1993) · doi:10.1002/1097-0142(19930301)71:5<1904::aid-cncr2820710530>3.0.co;2-x
Cited by
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
Butrynski, J. E., D'Adamo, D. R., Hornick, J. L., Dal Cin, P., Antonescu, C. R., Jhanwar, S. C., Ladanyi, M., Capelletti, M., Rodig, S. J., Ramaiya, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007056 · Cited by 870
Self-citationA Distinctive Subset of PEComas Harbors TFE3 Gene Fusions
Argani, P., Aulmann, S., Illei, P. B., Netto, G. J., Ro, J., Cho, H.-Y., Dogan, S., Ladanyi, M., Martignoni, G., Goldblum, J. R., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f17ac0 · Cited by 476
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
Lovly, C. M., Gupta, A., Lipson, D., Otto, G., Brennan, T., Chung, C. T., Borinstein, S. C., Ross, J. S., Stephens, P. J., Miller, V. A., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0377 · Cited by 455
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Mariño-Enríquez, A., Wang, W.-L., Roy, A., Lopez-Terrada, D., Lazar, A. J. F., Fletcher, C. D. M., Coffin, C. M., & Hornick, J. L. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318200cfd5 · Cited by 389
Self-citation
Metadata
- Authors
- Gleason, B. C., & Hornick, J. L.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2007-10-15
- Volume
- 61
- Issue
- 4
- Pages
- 428-437
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2148274228
- Cited by
- 757
- References
- 31
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.